mutual funds workshop health and technology: high-powered

6
AAII Journal/November 1998 3 MUTUAL FUNDS WORKSHOP As the stock market gives up ground, which it inevitably will do from time to time, investors often think about what they missed in the last run-up and how to position their portfolios for the equally inevitable next run-up. Just as investors might increase their cash positions in anticipation of a market decline or move from more aggressive stock holdings to less volatile stocks, in anticipation of the next great market surge investor’s thoughts often turn to the stocks and sectors with the greatest promise. What might first come to mind? Health and technology—health because of the aging population, gene research, new pharmaceuticals and drugs, and the promise of biotech in general; technology because, whatever technology is, it is synonymous with growth. Given the complexities of firms in these areas, sector funds in health and technology provide both specialized management and necessary diversification for investors interested in these sectors. It is often suggested, for example, when investing in biotech stocks that investing in one biotech stock is poten- tially disastrous, while a portfolio of biotech stocks is simply high risk. Few investors have the depth of knowledge or the experience in the health sciences to assemble a portfolio of 10 to 15 individual stocks in biotech, drugs and pharmaceuticals, and medical services and equipment. And the same is true for technology. While building a mutual fund portfolio made up solely of a few volatile sector funds is far from optimal for just about any individual investor, adding a few sector funds to an already diversified portfolio to boost the portfolio weightings in industries with exceptional long-term growth potential is a reasonable approach for many. The difficulty for investors beyond the deci- sion on the degree of portfolio commitment to any sector is deciphering just what specific sectors are in a health sector fund or a technology sector fund. Table 1 lists the no-load and low-load sector funds reported in The Indi- vidual Investor’s Guide to Low-Load Mutual Funds and the Quarterly Low- Load Mutual Fund Update that are health and technology related. While the health sector funds run the gamut from biotechnology to medical services delivery, they all arguably fall within the health classification. Where to draw the line on technology sector funds, however, is problematic. Are telecommunication firms providers of technology, enhancers of technology or users of technology? MCI and Worldcom, for instance, are in the telecommu- nication services industry, which is high tech, of course, but are they technol- ogy stocks? Probably not, but close. Two telecommunications sector funds, Fidelity Select Developing Communications and Fidelity Select Telecommuni- cations are included under technology in Table 1 for comparison, but reason- able arguments can be made that they are not truly technology funds. Inves- tors must make the final cut after reviewing their existing portfolio to deter- mine how any sector fund might create overlaps with existing holdings or fail to fill in portfolio sector gaps. HEALTH First, a look at the health sector funds. Listed are the top three sectors for By John Markese Given the complexities of companies in the health and technology fields, funds focusing on these sectors provide specialized management and diversification for investors interested in commitments in these areas. John Markese is president of AAII. The article was researched by Jean Henrich. HEALTH AND TECHNOLOGY: HIGH-POWERED SECTOR FUNDS

Upload: others

Post on 12-Feb-2022

3 views

Category:

Documents


0 download

TRANSCRIPT

AAII Journal/November 1998 3

MUTUAL FUNDS WORKSHOP

As the stock market gives up ground, which it inevitably will do from timeto time, investors often think about what they missed in the last run-up andhow to position their portfolios for the equally inevitable next run-up. Just asinvestors might increase their cash positions in anticipation of a marketdecline or move from more aggressive stock holdings to less volatile stocks, inanticipation of the next great market surge investor’s thoughts often turn tothe stocks and sectors with the greatest promise.

What might first come to mind? Health and technology—health because ofthe aging population, gene research, new pharmaceuticals and drugs, and thepromise of biotech in general; technology because, whatever technology is, itis synonymous with growth.

Given the complexities of firms in these areas, sector funds in health andtechnology provide both specialized management and necessary diversificationfor investors interested in these sectors. It is often suggested, for example,when investing in biotech stocks that investing in one biotech stock is poten-tially disastrous, while a portfolio of biotech stocks is simply high risk. Fewinvestors have the depth of knowledge or the experience in the health sciencesto assemble a portfolio of 10 to 15 individual stocks in biotech, drugs andpharmaceuticals, and medical services and equipment. And the same is truefor technology.

While building a mutual fund portfolio made up solely of a few volatilesector funds is far from optimal for just about any individual investor, addinga few sector funds to an already diversified portfolio to boost the portfolioweightings in industries with exceptional long-term growth potential is areasonable approach for many. The difficulty for investors beyond the deci-sion on the degree of portfolio commitment to any sector is deciphering justwhat specific sectors are in a health sector fund or a technology sector fund.

Table 1 lists the no-load and low-load sector funds reported in The Indi-vidual Investor’s Guide to Low-Load Mutual Funds and the Quarterly Low-Load Mutual Fund Update that are health and technology related.

While the health sector funds run the gamut from biotechnology to medicalservices delivery, they all arguably fall within the health classification. Whereto draw the line on technology sector funds, however, is problematic. Aretelecommunication firms providers of technology, enhancers of technology orusers of technology? MCI and Worldcom, for instance, are in the telecommu-nication services industry, which is high tech, of course, but are they technol-ogy stocks? Probably not, but close. Two telecommunications sector funds,Fidelity Select Developing Communications and Fidelity Select Telecommuni-cations are included under technology in Table 1 for comparison, but reason-able arguments can be made that they are not truly technology funds. Inves-tors must make the final cut after reviewing their existing portfolio to deter-mine how any sector fund might create overlaps with existing holdings or failto fill in portfolio sector gaps.

HEALTH

First, a look at the health sector funds. Listed are the top three sectors for

By John Markese

Given thecomplexities ofcompanies in thehealth andtechnology fields,funds focusing onthese sectors providespecializedmanagement anddiversification forinvestors interestedin commitments inthese areas.

John Markese is president of AAII. The article was researched by Jean Henrich.

HEALTH AND TECHNOLOGY:HIGH-POWERED SECTOR FUNDS

4 AAII Journal/November 1998

MUTUAL FUNDS WORKSHOP

TABLE 1. HEALTH AND TECHNOLOGY SECTOR FUNDS

Health Sector Funds (Ticker)Health Sector Funds (Ticker)Health Sector Funds (Ticker)Health Sector Funds (Ticker)Health Sector Funds (Ticker) Top 3 Sectors (Percentage of Portfolio)Top 3 Sectors (Percentage of Portfolio)Top 3 Sectors (Percentage of Portfolio)Top 3 Sectors (Percentage of Portfolio)Top 3 Sectors (Percentage of Portfolio) Top 5 Stocks (PercentagTop 5 Stocks (PercentagTop 5 Stocks (PercentagTop 5 Stocks (PercentagTop 5 Stocks (Percentag

Fidelity Select Biotechnology (FBIOX) biotech 43%, drugs 17%, pharmac’l preparations 7% Genentech 10.4%, Chiron 6.

Merck 5.7%, Schering-Ploug

T. Rowe Price Health Sciences (PRHSX) pharmac’ls 25%, biotech 21%, hospital supply & med devices 16% Collagen 3.7%, IDX Systems

Warner-Lambert 2.7%, Nati

INVESCO Strategic Health Sciences (FHLSX) drugs 57%, medical equip 18%, biotech 5% Merck 7.2%, Bristol-Myers S

Schering-Plough 5.6%, Ame

Vanguard Specialized Health Care (VGHCX) drugs & pharmac’ls 51%, international 21%, Warner-Lambert 5.9%, Pfizer

medical & dental instruments & supplies 8.5% Bristol-Myers Squibb 4.8%,

Fidelity Select Health Care (FSPHX) drugs 42%, medical supplies & appliances 12%, hospitals 4% American Home Products 7.

Merck 5.9%, Bristol-Myers

Fidelity Select Medical Delivery (FSHCX) hospitals 35%, HMOs & outpatient care 24%, medical servs 6% United HealthCare 8.2%, He

HEALTHSOUTH 6.9%, Colu

Technology Sector Funds (Ticker)Technology Sector Funds (Ticker)Technology Sector Funds (Ticker)Technology Sector Funds (Ticker)Technology Sector Funds (Ticker)

Fidelity Select Electronics (FSELX) semiconductors 29%, computers 23%, software & servs 13% Gateway 2000 6.0%, Hewlet

Microsoft 4.5%, ASM Lithog

T. Rowe Price Science & Technology (PRSCX) semiconductor 17%, commun’ns equip 14%, software 13% Parametric Technology 4.0%

Network Assoc. 3.4%, First

Fidelity Select Computers (FDCPX) computers 44%, semiconductors 16%, software & servs 11% Dell Computer 10.1%, EMC

Compaq Computer 4.1%, M

Fidelity Select Technology (FSPTX) software 16%, semiconductors 10%, microcomputers 5% Microsoft 9.7%, Selectron 4.

Micron Technology 2.7%, H

Fidelity Select Software & Comput Servs (FSCSX) software 54%, computer servs 10%, data process’g 6% Microsoft 11.2%, PeopleSoft

Siebel Systems 4.0%, Comp

Northern Technology (NTCHX) software & servs 36%, commun’ns equip 21%, Cisco Systems 4.7%, Lucent

electrical & electron compon 20% Dell Computer 4.4%, Yahoo

Robertson Stephens Information Age (RSIFX) software & servs 34%, semiconductors & compon 14%, Legato Systems 4.3%, Amer

commun’ns equip & servs 10% SAP AG 3.7%, Vitesse Sem

INVESCO Strategic Technology (FTCHX) software & servs 25%, computer hardware 13%, IBM 4.3%, Lexmark Int’l 3.2%

data process’g servs 10% CBT Group 2.8%, Ceridian 2

PBHG Technology & Communications (PBTCX) technology 63%, services 24%, health care 2% Ascend Comm 4.8%, J.D. Ed

Citrix Systems 4.0%, Comp

Fidelity Select Develop Commun (FSDCX) telephone equip 14%, telephone servs 12%, Cellstar 9.7%, Brightpoint 7.

wholesale electric appliances 10% Alcatel Alsthom 5.5%, Noki

Fidelity Select Telecommun (FSTCX) phone servs 47%, data commun equip 6%, WorldCom 8.6%, MCI Comm

TV & radio commun equip 5% AT&T 5.0%, Global Telesys

Source: Quarterly Low-Load Mutual Fund Update for statistics, with returns through Sept. 30, 1998; portfolio information supplied by the funds.

each fund with the percent of theportfolio by value invested in eachsector. In terms of the health carespectrum, Fidelity Select Biotechnol-ogy, with 43% in biotech, is at oneend, and Fidelity Select Medical

Delivery, with 35% of the portfolioinvested in the hospital category, isat the other end. These funds arelisted in rough order from thosecommitted significantly to biotech,through those that include drugs and

pharmaceuticals, medical devicesand, broader still, medical services.But funds report subsections andindustries differently, so sectorgrouping may be something differentfor each fund.

AAII Journal/November 1998 5

MUTUAL FUNDS WORKSHOP

e of Portfolio)e of Portfolio)e of Portfolio)e of Portfolio)e of Portfolio)

2%, Genzyme 5.8%, 62 162 1.49 3.00% front –1.0 11.5 10.6 16.7 –15.4 1.56

gh 4.4%

s 3.2%, Pfizer 2.7%, 77 133 1.35 none 0.5 na na 12.5 –15.4 na

onal Data 2.4%

Squibb 6.4%, Warner-Lambert 6.4%, 56 143 1.08 none 24.3 22.4 23.3 11.4 –10.5 1.26

erican Home Products 5.3%

r 5.2%, Pharmacia & Upjohn 5.1%, 99 10 0.40 1.00% 19.7 27.0 26.5 10.0 –10.5 0.96

, Abbott Laboratories 3.6% redemption fee

.9%, Warner-Lambert 7.6%, 62 59 1.33 3.00% front 29.3 27.1 29.7 11.6 –10.4 1.09

Squibb 4.9%, Schering-Plough 4.9%

alth Management Assoc. 8.0%, 49 109 1.57 3.00% front –17.0 6.3 14.6 12.0 –22.6 1.61

mbia/HCA Healthcare 5.7%, Tenet Healthcare 5.6%

t-Packard 5.9%, 104 435 1.18 3.00% front –25.6 11.2 25.4 17.4 –19.9 2.27

graphy 4.5%, Texas Instruments 3.3%

%, Analog Devices 3.5%, 51 125 0.97 none –15.5 4.4 15.6 14.9 –22.6 1.87

Data 3.3%, Maxim Integrated Products 3.2%

7.7%, Quantum 5.9%, 71 333 1.40 3.00% front 5.5 17.8 29.7 23.1 –14.0 2.29

Microsoft 4.1%

.2%, Dell Computer 4.0%, 108 556 1.38 3.00% front –4.2 11.9 20.2 17.5 –17.5 2.04

HBO & Co. 2.4%

t 7.5%, BMC Software 6.8%, 67 145 1.44 3.00% front 12.0 19.0 20.1 22.1 –18.3 1.96

puware 3.3%

t Technologies 4.5%, America Online 4.4%, 70 74 1.25 none 5.8 na na 18.0 –20.2 na

o 4.3%

rica Online 4.3%, Netword Assoc 3.7%, 46 369 1.82 none –16.0 na na 20.8 –24.4 na

miconductor 3.2%

%, Int’l Game Technology 3.2%, 120 237 1.05 none –9.3 12.5 16.0 10.9 –17.7 1.52

2.8%

dwards 4.6%; 64 259 1.30 none –19.7 21.6 na 17.3 –16.6 2.04

uware 3.9% Saville Systems 3.6%

.3%, Anicom 6.8%, 55 383 1.61 3.00% front –4.1 5.5 13.3 14.1 –20.3 1.96

a 4.3%

mun 7.5%, Tel-Save Holdings 6.6%, 31 157 1.51 3.00% front 7.1 12.5 13.4 14.2 –22.9 1.61

stems Group 3.6%

S&P 500 IndexS&P 500 IndexS&P 500 IndexS&P 500 IndexS&P 500 Index 9 .09 .09 .09 .09 .0 22 .522 .522 .522 .522 .5 19 .919 .919 .919 .919 .9 8 .08 .08 .08 .08 .0 –14.4–14.4–14.4–14.4–14.4 1 .121 .121 .121 .121 .12

S&P MidCap 400 IndexS&P MidCap 400 IndexS&P MidCap 400 IndexS&P MidCap 400 IndexS&P MidCap 400 Index –6.2–6.2–6.2–6.2–6.2 14 .114 .114 .114 .114 .1 13 .613 .613 .613 .613 .6 9 .99 .99 .99 .99 .9 18 .618 .618 .618 .618 .6 1 .321 .321 .321 .321 .32

Russell 2000 Small-Cap IndexRussell 2000 Small-Cap IndexRussell 2000 Small-Cap IndexRussell 2000 Small-Cap IndexRussell 2000 Small-Cap Index 19 .019 .019 .019 .019 .0 6 .86 .86 .86 .86 .8 9 .09 .09 .09 .09 .0 11 .111 .111 .111 .111 .1 –19.4–19.4–19.4–19.4–19.4 1 .421 .421 .421 .421 .42

Annual ReturnAnnual ReturnAnnual ReturnAnnual ReturnAnnual Return One-Month ReturnsOne-Month ReturnsOne-Month ReturnsOne-Month ReturnsOne-Month Returns (as of 9/30/98) (as of 9/30/98) (as of 9/30/98) (as of 9/30/98) (as of 9/30/98) Last Three YearsLast Three YearsLast Three YearsLast Three YearsLast Three Years TotalTotalTotalTotalTotal

No. ofNo. ofNo. ofNo. ofNo. of Portfol ioPortfol ioPortfol ioPortfol ioPortfol io ExpenseExpenseExpenseExpenseExpense MaximumMaximumMaximumMaximumMaximum One-One-One-One-One- Three-Three-Three-Three-Three- Five-Five-Five-Five-Five- High-High-High-High-High- Low-Low-Low-Low-Low- R iskR iskR iskR iskR iskStocksStocksStocksStocksStocks TurnoverTurnoverTurnoverTurnoverTurnover RatioRatioRatioRatioRatio LoadLoadLoadLoadLoad YearYearYearYearYear YearYearYearYearYear YearYearYearYearYear es tes tes tes tes t es tes tes tes tes t Index Index Index Index Index

(%) (%) (%) (%) (%) (%) (%) (%) (%) (%) (%)(%)(%)(%)(%) (%)(%)(%)(%)(%) (%)(%)(%)(%)(%) (%)(%)(%)(%)(%) (%)(%)(%)(%)(%) (%)(%)(%)(%)(%)

As for individual stocks, Merck isthe most prevalent in the top fiveholdings, but all the major drug/pharmaceuticals makers are there:Warner-Lambert, Bristol-MyersSquibb, Schering-Plough, Pfizer,

Pharmacia & Upjohn, and AmericaHome Products. Fidelity SelectBiotechnology and T.Rowe PriceHealth Sciences tend to hold morebiotech drug companies—higher risk,higher return, drug development

stocks.How diversified are these sector

funds? A diversified sector fund issurely an oxymoron, but the under-lying question is: how concentratedis the portfolio? Fidelity Select

6 AAII Journal/November 1998

MUTUAL FUNDS WORKSHOP

Biotechnology, for example, holds62 stocks, but 43% of the portfoliois in biotech and 10.4% is in onestock, Genentech, while the top fivestocks make up 32.5% of theportfolio. Contrast this with T.RowePrice Health Sciences, which has 77stock holdings, 25% in pharmaceuti-cals as the top sector holding,Collagen as the top stock at 3.7%,and the top five stocks totaling only14.7% of the portfolio. Even amongsector funds, diversification is anissue that should be addressed. Themore concentrated the sectors, topstocks and number of total stocks,the more likely the fund is to havehigher risk.

Portfolio turnover ratios give someindication of how aggressive thesefunds transact. Portfolio turnover isthe lower of purchases or sales as apercentage of portfolio value on anannual basis. A 100% turnover,about the average for a stock fund,indicates a complete turnover of theportfolio by value, not necessarily achange in all stock holdings, how-ever. Vanguard Specialized HealthCare is barely actively managed,with a 10% turnover, while FidelitySelect Biotechnology at 162% isaggressively managed—two differentinvestment management styles.Beyond brokerage costs, which aresmall per share at institutional rates,there is still the cost of the bid-askspread, the difference between thebuy price and sell price, a quarterpoint (0.25%) or less for large liquidstocks but higher for less liquidsmaller stocks. Brokerage costs andspreads reduce fund returns. Themore turnover the greater thetransaction costs, brokerage fees,and spread for a fund.

The expense ratio is a measure ofportfolio return drag. Expressed as apercentage of the portfolio value, theexpense ratio includes all manage-ment fees and fund costs, including,if the fund assesses one, the annual12b-1 distribution (marketing)charge, but does not include broker-age costs and front-end loads, back-end loads, or redemption charges.

The average expense ratio foraggressive growth funds, how mostof these funds would be classified, is1.3%. Vanguard Specialized HealthCare, demonstrating its fund family’sphilosophy, has a very low 0.40%ratio. The only fund noticeablyhigher than the average is FidelitySelect Medical at 1.57%, althoughnot high enough to sound an alarm.Returns for mutual funds arereported net of expenses, so theexpense ratio in essence has alreadybeen subtracted from the perfor-mance figures.

For each of these health sectorfunds, one-year, three-year, and five-year annualized returns are reportedand for comparison the returns forthe Standard & Poor’s 500 index(large stock benchmark) and theStandard & Poor’s 400 (mid-sizedbenchmark) are given. Two riskmeasures are provided to judge thesefund’s returns. The first risk measureis simple: What is the best and worstone-month return over the last threeyears? The second risk measure is aratio of the return volatility of thefund to the average return volatilityof all mutual funds. A 1.00 ratiowould be equal to the average totalmutual fund risk, and a ratio of 2.00would be twice as volatile, forexample.

With the exception of VanguardSpecialized Health Care, and to alesser extent, Fidelity Select HealthCare, these are volatile sector funds.A drop of 10.0% in a month duringa period without a bear marketwould take the breath away frommany investors. But these funds alsohave the upside, 12% and even 16%in a month. As a group over the lastthree years, those funds invested inthe large drug stocks did the best,hospital/medical delivery probablythe worst and biotech somewhere inbetween, three patterns within onegrowth sector.

TECHNOLOGY FUNDS

Technology breaks down intothree primary subsections based

upon the holdings of these sectorfunds: semiconductors, software, andcomputer hardware. The technologysector funds are roughly listed in thisorder so that funds with relatedsector allocations are close by foreasier comparisons. Looking at thetop five holdings column, it is clearthat many holdings are Microsoftand the computer makers: Gateway2000, Dell, Compaq, and IBM. AndInternet stocks have a presence withAmerica Online, Yahoo and others.Remember that the two telecommu-nication sector funds, Fidelity SelectDeveloping Communications andFidelity Select Telecommunications,don’t really fit the category; they area stretch to call technology but arehere for comparisons and informa-tion.

As a group, technology sectorfunds are more spread out byindustry and stock holdings than thehealth sector, getting back to thequestion of just what is technology.For example, PBHG Technology andCommunications has 63% intechnology, however they definetechnology.

About a third of these funds holdmore than 100 stocks. INVESCOStrategic Technology holds 120stocks, far more than required to bediversified, and its top five stockholdings add up to only 16.3% ofthe portfolio.

Portfolio turnover ratios of someof these sector funds can be shock-ingly high; 556%, 435%, 383%.These are aggressive funds investingin high growth, high-risk stocks, andthe technology area has been inconstant evolution, reshaping itselfrapidly. And some of these expenseratios—Robertson Stephens Informa-tion Age at 1.82%, for example—are on the high side. As a group,technology funds have highertransaction costs and expenses,which are easily forgotten if theyperform well.

Some of these funds beat the S&P500, a tough benchmark to best,recently and over five years. But therisks were equally tough to beat.

AAII Journal/November 1998 7

MUTUAL FUNDS WORKSHOP

The two funds that far outdid theS&P 500 (19.9%) over five yearswere Fidelity Select Computers(29.7%) and Fidelity Select Elec-tronic (25.4%), but they had totalrisk ratios of 2.29 and 2.27 respec-tively, well more than twice the riskratio of the 1.12 for the S&P 500.And don’t overlook the monthextremes, a few up over 20.0% in amonth and those same ones downover 14.0% in another. That isvolatility that few funds everdisplay.

A SECTOR FUND CHECKLIST

Additions of health and technologyfunds are sure to alter a portfolio’scharacter with the promise of highreturns and the likelihood of occa-sional nose dives. Before you investin any sector fund, make sure youget an annual report and prospectusand check off these points:• What is the investment objective

of the fund (how does the fundcharacterize its sector)?

• What are the top three subsectors

and what percentage do theyrepresent of the portfolio?

• Do these subsector weightingsmatch the investment objective asyou understand it?

• What are the major stock holdings?• Does this fund fill in gaps in your

portfolio or is it overlapping?• How has this fund performed

against similar sector funds andagainst basic market benchmarks?

• How jarring have the performancepotholes hit by the fund been andcan you stand the ride? ✦✦✦✦✦

www.aaii.com

Recent New Features for Members Only

Take a Refresher CourseSit in on investing mini-courses by following our InvestingPathways, found at the bottom right-hand column of ourhome page. Each month, a new Pathway begins, with adifferent stepping-stone added each week. Past topics canbe traveled by clicking on the Pathways graphic: Read aboutthe basics of investing; handling portfolio additions andwithdrawals; investing in DRPs; and choosing mutual funds.

Invest Like the ProsLearn methods for prospecting for stocks in our StockScreens section, found under Research in the left-handcolumn on our home page. Each month a different stockscreening method is highlighted. Included are the stockinvesting strategies of pros such as Warren Buffett, PeterLynch, James O’Shaughnessy, and William O’Neil. Also,performance charts show you how each strategy fares overtime.

Keep Current on Additions to our Web SiteWe’ve added a right-hand column to our site where wehighlight new material. Check this area for recent uploads ofAAII publications and special features.

Favorite Member AreasOf course, we continue to offer these valuable sections of our Web site:• AAII Journal archives back to 1991• Past and current Computerized Investing articles• Message boards• A robust download library• Local chapter meeting schedules

Check out our New Web Site Design!We’ve tinkered with our Web site to bring AAII’s wealth of information closer to your fingertips. Along with afreshened-up look, you’ll find your favorite sections and interesting new areas easier to locate.

www.aaii.com

How to Access Members Only AreasWhen prompted for authentication information toenter members only areas of the site, simply typein your AAII member number (from the mailinglabel on your AAII Journal) for both User Nameand Password. Be sure to use your entire eight-digit number, with no extra spaces.

AA

II Jo

urna

l/N

ovem

ber

199

85

MU

TU

AL

FU

ND

S W

OR

KS

HO

P

4A

AII

Jour

nal/

Nov

emb

er 1

998

MU

TU

AL

FU

ND

S W

OR

KS

HO

P

TAB

LE 1

. H

EA

LTH

AN

D T

EC

HN

OLO

GY

SE

CTO

R F

UN

DS

Hea

lth

Sec

tor

Fun

ds

(Tic

ker)

Hea

lth

Sec

tor

Fun

ds

(Tic

ker)

Hea

lth

Sec

tor

Fun

ds

(Tic

ker)

Hea

lth

Sec

tor

Fun

ds

(Tic

ker)

Hea

lth

Sec

tor

Fun

ds

(Tic

ker)

To

p 3

Sec

tors

(P

erce

nta

ge

of

Po

rtfo

lio

)T

op

3 S

ecto

rs (

Per

cen

tag

e o

f P

ort

foli

o)

To

p 3

Sec

tors

(P

erce

nta

ge

of

Po

rtfo

lio

)T

op

3 S

ecto

rs (

Per

cen

tag

e o

f P

ort

foli

o)

To

p 3

Sec

tors

(P

erce

nta

ge

of

Po

rtfo

lio

)T

op

5 S

tock

s (P

erce

nta

ge

of

Po

rtfo

lio

)T

op

5 S

tock

s (P

erce

nta

ge

of

Po

rtfo

lio

)T

op

5 S

tock

s (P

erce

nta

ge

of

Po

rtfo

lio

)T

op

5 S

tock

s (P

erce

nta

ge

of

Po

rtfo

lio

)T

op

5 S

tock

s (P

erce

nta

ge

of

Po

rtfo

lio

)

Fide

lity

Sel

ect

Bio

tech

nolo

gy (

FBIO

X)

biot

ech

43%

, dr

ugs

17%

, ph

arm

ac’l

prep

arat

ions

7%

Gen

ente

ch 1

0.4%

, C

hiro

n 6.

2%,

Gen

zym

e 5.

8%,

6216

21.

493.

00%

fro

nt–1

.011

.510

.616

.7–1

5.4

1.56

Mer

ck 5

.7%

, S

cher

ing-

Plou

gh 4

.4%

T. R

owe

Pric

e H

ealth

Sci

ence

s (P

RH

SX

)ph

arm

ac’ls

25%

, bi

otec

h 21

%,

hosp

ital

supp

ly &

med

dev

ices

16%

Col

lage

n 3.

7%,

IDX

Sys

tem

s 3.

2%,

Pfiz

er 2

.7%

,77

133

1.35

none

0.5

nana

12.5

–15.

4na

War

ner-

Lam

bert

2.7

%,

Nat

iona

l D

ata

2.4%

INV

ESC

O S

trat

egic

Hea

lth S

cien

ces

(FH

LSX

)dr

ugs

57%

, m

edic

al e

quip

18%

, bi

otec

h 5%

Mer

ck 7

.2%

, B

rist

ol-M

yers

Squ

ibb

6.4%

, W

arne

r-La

mbe

rt 6

.4%

,56

143

1.08

none

24.3

22.4

23.3

11.4

–10.

51.

26

Sch

erin

g-Pl

ough

5.6

%,

Am

eric

an H

ome

Prod

ucts

5.3

%

Van

guar

d S

peci

aliz

ed H

ealth

Car

e (V

GH

CX

)dr

ugs

& p

harm

ac’ls

51%

, in

tern

atio

nal

21%

,W

arne

r-La

mbe

rt 5

.9%

, Pf

izer

5.2

%,

Phar

mac

ia &

Upj

ohn

5.1%

,99

100.

401.

00%

19.7

27.0

26.5

10.0

–10.

50.

96 m

edic

al &

den

tal

inst

rum

ents

& s

uppl

ies

8.5%

Bri

stol

-Mye

rs S

quib

b 4.

8%,

Abb

ott

Labo

rato

ries

3.6

%re

dem

ptio

n fe

e

Fide

lity

Sel

ect

Hea

lth C

are

(FS

PHX

)dr

ugs

42%

, m

edic

al s

uppl

ies

& a

pplia

nces

12%

, ho

spita

ls 4

%A

mer

ican

Hom

e Pr

oduc

ts 7

.9%

, W

arne

r-La

mbe

rt 7

.6%

,62

591.

333.

00%

fro

nt29

.327

.129

.711

.6–1

0.4

1.09

Mer

ck 5

.9%

, B

rist

ol-M

yers

Squ

ibb

4.9%

, S

cher

ing-

Plou

gh 4

.9%

Fide

lity

Sel

ect

Med

ical

Del

iver

y (F

SH

CX

)ho

spita

ls 3

5%,

HM

Os

& o

utpa

tient

car

e 24

%,

med

ical

ser

vs 6

%U

nite

d H

ealth

Car

e 8.

2%,

Hea

lth M

anag

emen

t A

ssoc

. 8.

0%,

4910

91.

573.

00%

fro

nt–1

7.0

6.3

14.6

12.0

–22.

61.

61

HEA

LTH

SO

UTH

6.9

%,

Col

umbi

a/H

CA

Hea

lthca

re 5

.7%

, Te

net

Hea

lthca

re 5

.6%

Tec

hn

olo

gy

Sec

tor

Fun

ds

(Tic

ker)

Tec

hn

olo

gy

Sec

tor

Fun

ds

(Tic

ker)

Tec

hn

olo

gy

Sec

tor

Fun

ds

(Tic

ker)

Tec

hn

olo

gy

Sec

tor

Fun

ds

(Tic

ker)

Tec

hn

olo

gy

Sec

tor

Fun

ds

(Tic

ker)

Fide

lity

Sel

ect

Elec

tron

ics

(FS

ELX

)se

mic

ondu

ctor

s 29

%,

com

pute

rs 2

3%,

soft

war

e &

ser

vs 1

3%G

atew

ay 2

000

6.0%

, H

ewle

tt-Pa

ckar

d 5.

9%,

104

435

1.18

3.00

% f

ront

–25.

611

.225

.417

.4–1

9.9

2.27

Mic

roso

ft 4.

5%,

AS

M L

ithog

raph

y 4.

5%,

Texa

s In

stru

men

ts 3

.3%

T. R

owe

Pric

e S

cien

ce &

Tec

hnol

ogy

(PR

SC

X)

sem

icon

duct

or 1

7%,

com

mun

’ns

equi

p 14

%,

softw

are

13%

Para

met

ric T

echn

olog

y 4.

0%,

Ana

log

Dev

ices

3.5

%,

5112

50.

97no

ne–1

5.5

4.4

15.6

14.9

–22.

61.

87 N

etw

ork

Ass

oc.

3.4%

, Fi

rst

Dat

a 3.

3%,

Max

im I

nteg

rate

d Pr

oduc

ts 3

.2%

Fide

lity

Sel

ect

Com

pute

rs (

FDC

PX)

com

pute

rs 4

4%,

sem

icon

duct

ors

16%

, so

ftwar

e &

ser

vs 1

1%D

ell

Com

pute

r 10

.1%

, EM

C 7

.7%

, Q

uant

um 5

.9%

,71

333

1.40

3.00

% f

ront

5.5

17.8

29.7

23.1

–14.

02.

29

Com

paq

Com

pute

r 4.

1%,

Mic

roso

ft 4.

1%

Fide

lity

Sel

ect

Tech

nolo

gy (

FSPT

X)

softw

are

16%

, se

mic

ondu

ctor

s 10

%,

mic

roco

mpu

ters

5%

Mic

roso

ft 9.

7%,

Sel

ectr

on 4

.2%

, D

ell

Com

pute

r 4.

0%,

108

556

1.38

3.00

% f

ront

–4.2

11.9

20.2

17.5

–17.

52.

04

Mic

ron

Tech

nolo

gy 2

.7%

, H

BO

& C

o. 2

.4%

Fide

lity

Sel

ect

Sof

twar

e &

Com

put

Ser

vs (

FSC

SX

)so

ftwar

e 54

%,

com

pute

r se

rvs

10%

, da

ta p

roce

ss’g

6%

Mic

roso

ft 11

.2%

, Pe

ople

Sof

t 7.

5%,

BM

C S

oftw

are

6.8%

,67

145

1.44

3.00

% f

ront

12.0

19.0

20.1

22.1

–18.

31.

96 S

iebe

l S

yste

ms

4.0%

, C

ompu

war

e 3.

3%

Nor

ther

n Te

chno

logy

(N

TCH

X)

softw

are

& s

ervs

36%

, co

mm

un’n

s eq

uip

21%

,C

isco

Sys

tem

s 4.

7%,

Luce

nt T

echn

olog

ies

4.5%

, A

mer

ica

Onl

ine

4.4%

,70

741.

25no

ne5.

8na

na18

.0–2

0.2

na

ele

ctric

al &

ele

ctro

n co

mpo

n 20

% D

ell

Com

pute

r 4.

4%,

Yah

oo 4

.3%

Rob

erts

on S

teph

ens

Info

rmat

ion

Age

(R

SIF

X)

softw

are

& s

ervs

34%

, se

mic

ondu

ctor

s &

com

pon

14%

,Le

gato

Sys

tem

s 4.

3%,

Am

eric

a O

nlin

e 4.

3%,

Net

wor

d A

ssoc

3.7

%,

4636

91.

82no

ne–1

6.0

nana

20.8

–24.

4na

com

mun

’ns

equi

p &

ser

vs 1

0% S

AP

AG

3.7

%,

Vite

sse

Sem

icon

duct

or 3

.2%

INV

ESC

O S

trat

egic

Tec

hnol

ogy

(FTC

HX

)so

ftwar

e &

ser

vs 2

5%,

com

pute

r ha

rdw

are

13%

,IB

M 4

.3%

, Le

xmar

k In

t’l 3

.2%

, In

t’l G

ame

Tech

nolo

gy 3

.2%

,12

023

71.

05no

ne–9

.312

.516

.010

.9–1

7.7

1.52

dat

a pr

oces

s’g

serv

s 10

% C

BT

Gro

up 2

.8%

, C

erid

ian

2.8%

PBH

G T

echn

olog

y &

Com

mun

icat

ions

(PB

TCX

)te

chno

logy

63%

, se

rvic

es 2

4%,

heal

th c

are

2%A

scen

d C

omm

4.8

%,

J.D

. Ed

war

ds 4

.6%

;64

259

1.30

none

–19.

721

.6na

17.3

–16.

62.

04

Citr

ix S

yste

ms

4.0%

, C

ompu

war

e 3.

9% S

avill

e S

yste

ms

3.6%

Fide

lity

Sel

ect

Dev

elop

Com

mun

(FS

DC

X)

tele

phon

e eq

uip

14%

, te

leph

one

serv

s 12

%,

Cel

lsta

r 9.

7%,

Bri

ghtp

oint

7.3

%,

Ani

com

6.8

%,

5538

31.

613.

00%

fro

nt–4

.15.

513

.314

.1–2

0.3

1.96

who

lesa

le e

lect

ric

appl

ianc

es 1

0% A

lcat

el A

lsth

om 5

.5%

, N

okia

4.3

%

Fide

lity

Sel

ect

Tele

com

mun

(FS

TCX

)ph

one

serv

s 47

%,

data

com

mun

equ

ip 6

%,

Wor

ldC

om 8

.6%

, M

CI

Com

mun

7.5

%,

Tel-S

ave

Hol

ding

s 6.

6%,

3115

71.

513.

00%

fro

nt7.

112

.513

.414

.2–2

2.9

1.61

TV

& r

adio

com

mun

equ

ip 5

% A

T&T

5.0%

, G

loba

l Te

lesy

stem

s G

roup

3.6

%

S&

P 5

00 I

nd

exS

&P

500

In

dex

S&

P 5

00 I

nd

exS

&P

500

In

dex

S&

P 5

00 I

nd

ex9

.09

.09

.09

.09

.02

2.5

22

.52

2.5

22

.52

2.5

19

.91

9.9

19

.91

9.9

19

.98

.08

.08

.08

.08

.0–1

4.4

–14

.4–1

4.4

–14

.4–1

4.4

1.1

21

.12

1.1

21

.12

1.1

2

S&

P M

idC

ap 4

00 I

nd

exS

&P

Mid

Cap

400

In

dex

S&

P M

idC

ap 4

00 I

nd

exS

&P

Mid

Cap

400

In

dex

S&

P M

idC

ap 4

00 I

nd

ex–6

.2–6

.2–6

.2–6

.2–6

.21

4.1

14

.11

4.1

14

.11

4.1

13

.61

3.6

13

.61

3.6

13

.69

.99

.99

.99

.99

.91

8.6

18

.61

8.6

18

.61

8.6

1.3

21

.32

1.3

21

.32

1.3

2

Ru

ssel

l 20

00 S

mal

l-C

ap I

nd

exR

uss

ell

2000

Sm

all-

Cap

In

dex

Ru

ssel

l 20

00 S

mal

l-C

ap I

nd

exR

uss

ell

2000

Sm

all-

Cap

In

dex

Ru

ssel

l 20

00 S

mal

l-C

ap I

nd

ex1

9.0

19

.01

9.0

19

.01

9.0

6.8

6.8

6.8

6.8

6.8

9.0

9.0

9.0

9.0

9.0

11

.11

1.1

11

.11

1.1

11

.1–1

9.4

–19

.4–1

9.4

–19

.4–1

9.4

1.4

21

.42

1.4

21

.42

1.4

2S

ourc

e: Q

uart

erly

Low

-Loa

d M

utua

l Fun

d U

pdat

e fo

r st

atis

tics,

with

ret

urns

thro

ugh

Sep

t. 30

, 199

8; p

ortf

olio

info

rmat

ion

supp

lied

by th

e fu

nds.

An

nu

al R

etu

rnA

nn

ual

Ret

urn

An

nu

al R

etu

rnA

nn

ual

Ret

urn

An

nu

al R

etu

rnO

ne-

Mo

nth

Ret

urn

sO

ne-

Mo

nth

Ret

urn

sO

ne-

Mo

nth

Ret

urn

sO

ne-

Mo

nth

Ret

urn

sO

ne-

Mo

nth

Ret

urn

s (

as o

f 9/

30/9

8) (

as o

f 9/

30/9

8) (

as o

f 9/

30/9

8) (

as o

f 9/

30/9

8) (

as o

f 9/

30/9

8)La

st T

hre

e Y

ears

Last

Th

ree

Yea

rsLa

st T

hre

e Y

ears

Last

Th

ree

Yea

rsLa

st T

hre

e Y

ears

To

tal

To

tal

To

tal

To

tal

To

tal

No

. o

fN

o.

of

No

. o

fN

o.

of

No

. o

fP

ort

foli

oP

ort

foli

oP

ort

foli

oP

ort

foli

oP

ort

foli

oE

xpen

seE

xpen

seE

xpen

seE

xpen

seE

xpen

seM

axim

um

Max

imu

mM

axim

um

Max

imu

mM

axim

um

On

e-O

ne-

On

e-O

ne-

On

e-T

hre

e-T

hre

e-T

hre

e-T

hre

e-T

hre

e-Fi

ve-

Five

-Fi

ve-

Five

-Fi

ve-

Hig

h-

Hig

h-

Hig

h-

Hig

h-

Hig

h-

Low

-Lo

w-

Low

-Lo

w-

Low

-R

isk

Ris

kR

isk

Ris

kR

isk

Sto

cks

Sto

cks

Sto

cks

Sto

cks

Sto

cks

Tu

rno

ver

Tu

rno

ver

Tu

rno

ver

Tu

rno

ver

Tu

rno

ver

Rat

ioR

atio

Rat

ioR

atio

Rat

ioLo

adLo

adLo

adLo

adLo

adY

ea

rY

ea

rY

ea

rY

ea

rY

ea

rY

ea

rY

ea

rY

ea

rY

ea

rY

ea

rY

ea

rY

ea

rY

ea

rY

ea

rY

ea

re

ste

ste

ste

ste

ste

ste

ste

ste

ste

st

Ind

ex

Ind

ex

Ind

ex

Ind

ex

Ind

ex (

%)

(%

) (

%)

(%

) (

%)

(%

) (

%)

(%

) (

%)

(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)(%

)

each

fun

d w

ith

the

perc

ent

of t

hepo

rtfo

lio b

y va

lue

inve

sted

in

each

sect

or.

In t

erm

s of

the

hea

lth

care

spec

trum

, Fi

delit

y Se

lect

Bio

tech

nol-

ogy,

wit

h 43

% i

n bi

otec

h, i

s at

one

end,

and

Fid

elit

y Se

lect

Med

ical

Del

iver

y, w

ith

35%

of

the

port

folio

inve

sted

in

the

hosp

ital

cat

egor

y, i

sat

the

oth

er e

nd.

The

se f

unds

are

liste

d in

rou

gh o

rder

fro

m t

hose

com

mit

ted

sign

ific

antl

y to

bio

tech

,th

roug

h th

ose

that

inc

lude

dru

gs a

nd

phar

mac

euti

cals

, m

edic

al d

evic

esan

d, b

road

er s

till,

med

ical

ser

vice

s.B

ut f

unds

rep

ort

subs

ecti

ons

and

indu

stri

es d

iffe

rent

ly,

so s

ecto

rgr

oupi

ng m

ay b

e so

met

hing

dif

fere

ntfo

r ea

ch f

und.

As

for

indi

vidu

al s

tock

s, M

erck

is

the

mos

t pr

eval

ent

in t

he t

op f

ive

hold

ings

, bu

t al

l th

e m

ajor

dru

g/ph

arm

aceu

tica

ls m

aker

s ar

e th

ere:

War

ner-

Lam

bert

, B

rist

ol-M

yers

Squi

bb,

Sche

ring

-Plo

ugh,

Pfi

zer,

Phar

mac

ia &

Upj

ohn,

and

Am

eric

aH

ome

Prod

ucts

. Fi

delit

y Se

lect

Bio

tech

nolo

gy a

nd T

.Row

e Pr

ice

Hea

lth

Scie

nces

ten

d to

hol

d m

ore

biot

ech

drug

com

pani

es—

high

er r

isk,

high

er r

etur

n, d

rug

deve

lopm

ent

stoc

ks.

How

div

ersi

fied

are

the

se s

ecto

rfu

nds?

A d

iver

sifi

ed s

ecto

r fu

nd i

ssu

rely

an

oxym

oron

, bu

t th

e un

der-

lyin

g qu

esti

on i

s: h

ow c

once

ntra

ted

is t

he p

ortf

olio

? Fi

delit

y Se

lect